MATERIAL SAFETY DATA SHEET
SECTION 1 - IDENTIFICATION OF PRODUCT AND COMPANY
1-866-531-8896
Pfizer Inc Emergency telephone
24 Hours
Pfizer Animal Health Hours of operation
1-800-366-5288
235 East 42nd Street Telephone
New York, NY 10017
Trade names Primucell FIP 庐
Product name Primucell FIP 庐
Veterinary Vaccine
Therapeutic use
Lyophilised powder
Description
SECTION 2 - COMPOSITION
Ingredient CAS Number Amount
Feline Infectious Peritonitis - Modified live virus Not assigned Proprietary
Appropriate cell substrates Not assigned Proprietary
Short chain peptide Not assigned <30%
Sucrose* 57-50-1 <40%
Gelatin 9000-70-8 <30%
Gentamicin* 1403-66-3 <0.1%
Non-hazardous ingredients Not applicable <1.0%
*Hazardous
Note: Ingredient(s) indicated as hazardous have been assessed under standards
for workplace safety.
SECTION 3 - HAZARDS IDENTIFICATION
Not applicable
Signal word
Not applicable
Statements of hazard
None known; however, direct contact with any foreign material may cause
Eye effects
eye irritation.
Not known
Skin effects
Inhalation effects Repeated exposure to dust or mist may produce allergic reactions. An
Occ upational Exposure Limit has been established for one or more of the
ingredients (see Section 8).
Ingestion effects Toxicity following ingestion is not expected.Ingestion should be avoided.
Inhalation, skin contact, or ingestion.
Route of entry
10000403 - Primucell FIP庐 Pfizer Inc.
Revision date: 03/25/94, Version: 1.0.0 Page 1 of 5
SECTION 3 - HAZARDS IDENTIFICATION ... continued
This document has been prepared in accordance with standards for
NOTE:
workplace safety, which require the inclusion of all known hazards of the
product or its ingredients regardless of the potential risk. The
precautionary statements and warnings included may not apply in all
cases. Your needs may vary depending upon the potential for exposure in
your workplace.
SECTION 4 - FIRST AID MEASURES
IN CASE OF ACCIDENTAL INNOCULATION, CONSULT THE
Skin
EMERGENCY CONTACT LISTED IN SECTION 1. In case of direct
skin contact, remove contaminated clothing and flush exposed area with
large amounts of water. Obtain medical assistance.
Eyes Immediately flush eyes with water for at least 15 minutes. If irritation
occurs or persists, get medical attention.
Inhalation Remove to fresh air. If discomfort persists, get medical attention.
In the event of swallowing this material, seek immediate medical attention.
Ingestion
SECTION 5 - FIRE FIGHTING MEASURES
This material is not expected to support combustion.
General hazard
Wear approved positive pressure, self-contained breathing apparatus and
Fire fighting instructions
full protective turn out gear. Move containers from fire area if possible
without increased personal risk. Dike area if possible to contain water for
later disposal.
Use carbon dioxide, dry chemical, or water spray.
Extinguishing media
Expected to be >55掳C
Flash point
Toxic or corrosive gases are expected in fires involving this mixture.
Hazardous combustion
products
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Review Sections 3, 8 and 12 before proceeding with clean up.
General
Sweep spilled material into an approved container for disposal keeping
Small spill
dust generation to a minimum. Clean spill area thoroughly. Prevent
discharge to drains.
Large spill Contain the source of the spill or leak if it is safe to do so. Sweep spilled
material into an approved container for disposal keeping dust generation to
a minimum. Clean spill area thoroughly. Prevent discharge to drains.
10000403 - Primucell FIP庐 Pfizer Inc.
Revision date: 03/25/94, Version: 1.0.0 Page 2 of 5
SECTION 7 - HANDLING AND STORAGE
General handling Avoid contact with eyes, skin and clothing. Avoid breathing dust.
Follow product information storage instructions to maintain efficacy. Do
Storage conditions
not freeze. No other storage requirements are necessary concerning
occupational hazards.
SECTION 8 - EXPOSURE CONTROLS/PERSONAL PROTECTION
Exposure limits
Compound Issuer Type OEL
Sucrose OSHA TWA-8 Hr 5 mg/m鲁 (respirable fraction)
OSHA TWA-8 Hr 15 mg/m鲁 (total dust)
ACGIH TWA-8 Hr 10 mg/m鲁
UK OES TWA-8 Hr 10 mg/m鲁
The exposure limit(s) listed for solid components are only relevant if dust
Exposure information
may be generated.
Good general ventilation should be sufficient to control airborne levels.
Ventilation
Respiratory protection Respirators are not required for normal use of this material. Use dust mask
for dusty conditions.
Wear safety glasses with sideshields if eye contact is possible.
Eye protection
Wear protective clothing with long sleeves to avoid routine skin contact.
Skin protection
Wash hands and arms thoroughly after handling this material. Clean up
spills immediately.
Wear latex or other impervious gloves if skin contact is possible.
Hand protection
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Lyophilized powder
Physical form
No data available
Color
Mixture
Molecular weight
Mixture
Molecular formula
No data available
pH
No data available
Boiling point
No data available
Melting point
No data available
Density
No data available
Vapor pressure
Components are soluble in water
Water solubility
10000403 - Primucell FIP庐 Pfizer Inc.
Revision date: 03/25/94, Version: 1.0.0 Page 3 of 5
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ... continued
No data available
Solvent solubility
SECTION 10 - STABILITY AND REACTIVITY
This material is Stable
Reactivity
Avoid freezing and storage at temperatures greater than 7掳 C.
Conditions to avoid
This material can be denatured or inactivated by a variety of organic
Incompatibilities
solvents, salts or heavy metals.
None expected under normal conditions.
Hazardous
decomposition
products
Not expected to occur
Hazardous
polymerization
This material is non flammable.
Explosive properties
SECTION 11 - TOXICOLOGY INFORMATION
Acute toxicity
Compound Type Route Species Dosage
Sucrose LD 50 Oral Rat 29,700 mg/kg
Eye Not determined for this mixture. Irritation is not expected to occur based
on components.
Skin Not determined for this mixture. Irritation is not expected to occur based
on components.
Not determined for this mixture.
Inhalation
Not determined for this mixture. Toxicity is not expected following
Ingestion
ingestion.
Not determined for this mixture.
Mutagenicity
Sensitization (allergic skin reaction) may occur, based on effects of
Sensitization
individual components.
Not determined for this mixture.
Subchronic effects
Not determined for this mixture.
Chronic effects/
carcinogenicity
None of the components of this formulation is listed as a carcinogen by
Carcinogen status
IARC, NTP or OSHA.
Not determined
Reproductive effects
10000403 - Primucell FIP庐 Pfizer Inc.
Revision date: 03/25/94, Version: 1.0.0 Page 4 of 5
SECTION 11 - TOXICOLOGY INFORMATION ... continued
The effects on developing offspring are not known.
Teratogenicity
This mixture contains a modified live feline virus vaccine for use in cats.
Additional information
SECTION 12 - ECOLOGICAL INFORMATION
The environmental characteristics of this mixture have not been fully
Environmental overview
evaluated. Releases to the environment should be avoided.
SECTION 13 - DISPOSAL INFORMATION
Observe all local and national regulations when disposing of this mixture.
Disposal procedure
For large quantities, dispose of waste on site in a biomedical incinerator if
allowed by the incinerator permit. If no on-site incinerator is available,
dispose of waste in a licensed biomedical incinerator.
SECTION 14 - TRANSPORTATION INFORMATION
Not regulated for transport under USDOT, EUADR, IATA, or IMDG
General shipping
regulations.
instructions
SECTION 15 - REGULATORY INFORMATION
Not classified
EU Classification
This product has been classified in accordance with the hazard criteria of
Canadian WHMIS
the CPR and the MSDS contains all of the information required by the
CPR.
SECTION 16 - OTHER
Disclaimer Pfizer Inc believes that the information contained in this Material
Safety Data Sheet is accurate, and while it is provided in good faith, it
is without a warranty of any kind, expressed or implied.
10000403 - Primucell FIP庐 Pfizer Inc.
Revision date: 03/25/94, Version: 1.0.0 Page 5 of 5
|